1,945
Views
30
CrossRef citations to date
0
Altmetric
Reviews

The multifaceted impact of pneumococcal conjugate vaccine implementation in children in France between 2001 to 2014

, &
Pages 277-284 | Received 25 Sep 2015, Accepted 02 Nov 2015, Published online: 23 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Brandon Essink, James Peterson, Kari Yacisin, Himal Lal, Sarah Mirza, Xia Xu, Ingrid L. Scully, Daniel A. Scott, William C. Gruber, Kathrin U. Jansen & Wendy Watson. (2021) A randomized phase 1/2 study of the safety and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy adults 50 through 85 years of age. Human Vaccines & Immunotherapeutics 17:8, pages 2691-2699.
Read now
Asrul Akmal Shafie, Norazah Ahmad, Jerusha Naidoo, Chee Yoong Foo, Callix Wong, Sarah Pugh & Kah Kee Tan. (2020) Estimating the population health and economic impacts of introducing a pneumococcal conjugate vaccine in Malaysia- an economic evaluation. Human Vaccines & Immunotherapeutics 16:7, pages 1719-1727.
Read now
Lijoy Varghese, Bruce Mungall, Xu-Hao Zhang & Bernard Hoet. (2016) Response to Wu et al. — Cost-effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong. Human Vaccines & Immunotherapeutics 12:10, pages 2675-2680.
Read now

Articles from other publishers (27)

Corinne Levy, Emmanuelle Varon, Philippe Bidet, Stéphane Béchet, Christophe Batard, Alain Wollner, Franck Thollot, Stéphane Bonacorsi & Robert Cohen. (2023) Otorrhea bacterial profile, epidemiology before widespread use of the third-generation pneumococcal conjugate vaccine in French children, a prospective study from 2015 to 2023. Infectious Diseases Now 53:6, pages 104738.
Crossref
Zein Assad, Zaba Valtuille, Alexis Rybak, Florentia Kaguelidou, Andrea Lazzati, Emmanuelle Varon, Luu-Ly Pham, Léa Lenglart, Albert Faye, Marion Caseris, Robert Cohen, Corinne Levy, Astrid Vabret, François Gravey, François Angoulvant, Bérengère Koehl & Naïm Ouldali. (2023) Unique Changes in the Incidence of Acute Chest Syndrome in Children With Sickle Cell Disease Unravel the Role of Respiratory Pathogens. CHEST.
Crossref
Alexis Rybak, Corinne Levy, Naïm Ouldali, Stéphane Bonacorsi, Stéphane Béchet, Jean-François Delobbe, Christophe Batard, Isabelle Donikian, Marie Goldrey, Jessica Assouline, Robert Cohen & Emmanuelle Varon. (2023) Dynamics of Antibiotic Resistance of Streptococcus pneumoniae in France: A Pediatric Prospective Nasopharyngeal Carriage Study from 2001 to 2022. Antibiotics 12:6, pages 1020.
Crossref
I. O. Stoma. (2023) Vaccination as a strategy to overcome antimicrobial resistance: a fresh look on a well-known problem. Journal Infectology 15:1, pages 5-15.
Crossref
Haider N. Dawood, Ali H. Al-Jumaili, Ahmed H. Radhi, Delan Ikram & Ali Al-Jabban. (2023) Emerging pneumococcal serotypes in Iraq: scope for improved vaccine development. F1000Research 12, pages 435.
Crossref
Zein Assad, Morgane Michel, Zaba Valtuille, Andrea Lazzati, Priscilla Boizeau, Fouad Madhi, Jean Gaschignard, Luu-Ly Pham, Marion Caseris, Robert Cohen, Florentia Kaguelidou, Emmanuelle Varon, Corinne Alberti, Albert Faye, François Angoulvant, Bérengère Koehl & Naïm Ouldali. (2022) Incidence of Acute Chest Syndrome in Children With Sickle Cell Disease Following Implementation of the 13-Valent Pneumococcal Conjugate Vaccine in France. JAMA Network Open 5:8, pages e2225141.
Crossref
Kevin Cannon, Charles Elder, Mariano Young, Daniel A. Scott, Ingrid L. Scully, Gary Baugher, Yahong Peng, Kathrin U. Jansen, William C. Gruber & Wendy Watson. (2021) A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination. Vaccine 39:51, pages 7494-7502.
Crossref
Matt D. Wasserman, Johnna Perdrizet, Lindsay Grant, Kyla Hayford, Shubhra Singh, Paranjoy Saharia, Emily K. Horn & Raymond A. Farkouh. (2021) Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age. Infectious Diseases and Therapy 10:4, pages 2701-2720.
Crossref
Samanta C. G. Almeida, Stephanie W. Lo, Paulina A. Hawkins, Rebecca A. Gladstone, Ana Paula Cassiolato, Keith P. Klugman, Robert F. Breiman, Stephen D. Bentley, Lesley McGee & Maria-Cristina de C. Brandileone. (2021) Genomic surveillance of invasive Streptococcus pneumoniae isolates in the period pre-PCV10 and post-PCV10 introduction in Brazil. Microbial Genomics 7:10.
Crossref
Markus A. Rose, Maren Laurenz, Ralf Sprenger, Matthias Imöhl & Mark van der Linden. (2021) Nasopharyngeal Carriage in Children After the Introduction of Generalized Infant Pneumococcal Conjugate Vaccine Immunization in Germany. Frontiers in Medicine 8.
Crossref
Emilie Coronas, Alain Martinot, Emmanuelle Varon, Frédéric Wallet & François Dubos. (2021) Stable Incidence of Invasive Pneumococcal Disease in Children in Northern France From 2014 Through 2018. Pediatric Infectious Disease Journal 40:7, pages 688-693.
Crossref
Shalom Ben-Shimol, Noga Givon-Lavi, Leore Kotler, Bart Adriaan van der Beek, David Greenberg & Ron Dagan. (2021) Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines. Emerging Infectious Diseases 27:1, pages 150-160.
Crossref
Diariatou Diallo, Claire Santal, Marion Lagrée, Alain Martinot & François Dubos. (2020) Vaccination coverage of children with chronic diseases is inadequate especially for specifically recommended vaccines. Acta Paediatrica 109:12, pages 2677-2684.
Crossref
Philippe Buchy, Sibel Ascioglu, Yves Buisson, Sanjoy Datta, Michael Nissen, Paul Anantharajah Tambyah & Sirenda Vong. (2020) Impact of vaccines on antimicrobial resistance. International Journal of Infectious Diseases 90, pages 188-196.
Crossref
Parveen Fathima, Heather F Gidding, Peter B McIntyre, Thomas L Snelling, Lisa McCallum, Nicholas de Klerk, Christopher C Blyth, Bette Liu & Hannah C Moore. (2019) Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study. The Lancet Child & Adolescent Health 3:10, pages 713-724.
Crossref
Godwin Oligbu, Sarah Collins, Abdelmajid Djennad, Carmen L. Sheppard, Norman K. Fry, Nick J. Andrews, Ray Borrow, Mary E. Ramsay & Shamez N. Ladhani. (2019) Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000–June 30, 2016. Emerging Infectious Diseases 25:9, pages 1708-1718.
Crossref
Allison Thompson, Erik Lamberth, Joseph Severs, Ingrid Scully, Sanela Tarabar, John Ginis, Kathrin U. Jansen, William C. Gruber, Daniel A. Scott & Wendy Watson. (2019) Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults. Vaccine 37:42, pages 6201-6207.
Crossref
Audrey Vincent, Stéphane Bonacorsi, Emmanuelle Varon, Stéphane Dauger & Michael Levy. (2019) Serotype 14 pneumococcal bacteremia: From one neonate to another in a pediatric intensive care unit. Infection Control & Hospital Epidemiology 40:8, pages 952-953.
Crossref
Enrique Chacon-Cruz, Rosa Maria Rivas-Landeros, Maria Luisa Volker-Soberanes, Erika Zoe Lopatynsky-Reyes, Chandra Becka & Jorge Arturo Alvelais-Palacios. (2019) 12 years active surveillance for pediatric pleural empyema in a Mexican hospital: effectiveness of pneumococcal 13-valent conjugate vaccine, and early emergence of methicillin-resistant Staphylococcus aureus . Therapeutic Advances in Infectious Disease 6, pages 204993611983931.
Crossref
Enrique Chacon-Cruz, Christopher Roberts, Rosa Maria Rivas-Landeros, Erika Zoe Lopatynsky-Reyes, Lucila Alejandra Almada-Salazar & Jorge Arturo Alvelais-Palacios. (2019) Pediatric meningitis due to Neisseria meningitidis, Streptococcus pneumoniae and Group B Streptococcus in Tijuana, Mexico: active/prospective surveillance, 2005–2018 . Therapeutic Advances in Infectious Disease 6, pages 204993611983227.
Crossref
Corinne Levy, François Vie le Sage, Emmanuelle Varon, Martin Chalumeau, Emmanuel Grimprel & Robert Cohen. (2018) Pediatric Ambulatory and Hospital Networks for Surveillance and Clinical Epidemiology of Community-Acquired Infections. The Journal of Pediatrics 194, pages 269-270.e2.
Crossref
Lucy McDonnell, David Armstrong, Mark Ashworth, Alexandru Dregan, Umer Malik & Patrick White. (2017) National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries. Journal of Antimicrobial Chemotherapy 72:11, pages 3199-3204.
Crossref
Abdullah AlqayoudhiMaryke NielsenNicola O’SullivanMary CorcoranPatrick J. GavinKarina M. ButlerRobert CunneyRichard J. Drew. (2017) Clinical Utility of Polymerase Chain Reaction Testing for Streptococcus pneumoniae in Pediatric Cerebrospinal Fluid Samples. Pediatric Infectious Disease Journal 36:9, pages 833-836.
Crossref
Diarmaid Hughes & Dan I Andersson. (2017) Environmental and genetic modulation of the phenotypic expression of antibiotic resistance. FEMS Microbiology Reviews 41:3, pages 374-391.
Crossref
Andrew B Janowski & Jason G Newland. (2017) From the microbiome to the central nervous system, an update on the epidemiology and pathogenesis of bacterial meningitis in childhood. F1000Research 6, pages 86.
Crossref
M. Killian, M. Detoc, P. Berthelot, R. Charles, A. Gagneux-Brunon, F. Lucht, C. Pulcini, S. Barbois & E. Botelho-Nevers. (2016) Vaccine hesitancy among general practitioners: evaluation and comparison of their immunisation practice for themselves, their patients and their children. European Journal of Clinical Microbiology & Infectious Diseases 35:11, pages 1837-1843.
Crossref
Karen M. Miernyk, Lisa R. Bulkow, Samantha L. Case, Tammy Zulz, Michael G. Bruce, Marcella Harker-Jones, Debby A. Hurlburt, Thomas W. Hennessy & Karen M. Rudolph. (2016) Population structure of invasive Streptococcus pneumoniae isolates among Alaskan children in the conjugate vaccine era, 2001 to 2013. Diagnostic Microbiology and Infectious Disease 86:2, pages 224-230.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.